Neurim Pharmaceuticals
Israel - Tel AvivPharmaceutical
Focus: Neurim Pharmaceuticals is an Israeli CNS-focused pharmaceutical company founded in 2001, specializing in neurological and sleep disorders through melatonin-based and novel therapeutic approaches.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Neurim Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Neurim Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
5 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Circadin
Stable
Growth
Flagship multi-indication melatonin formulation with Phase 3/4 programs spanning multiple CNS and metabolic indications.
Pipeline & Clinical Trials
Help build intelligence for Neurim Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.